Tetanus adjunct treatment

Tetanus adjunct treatment refers to supportive and symptomatic pharmacotherapies administered alongside primary antitoxin neutralization, wound debridement, and antimicrobial therapy in patients suffering from active tetanus

Tetanus adjunct treatment refers to supportive and symptomatic pharmacotherapies administered alongside primary antitoxin neutralization, wound debridement, and antimicrobial therapy in patients suffering from active tetanus

Tetanus is a life-threatening, non-communicable neurological disease caused by tetanospasmin, a potent neurotoxin produced by the anaerobic bacterium *Clostridium tetani*

Tetanus is a life-threatening, non-communicable neurological disease caused by tetanospasmin, a potent neurotoxin produced by the anaerobic bacterium *Clostridium tetani* The toxin enters peripheral motor nerves and undergoes retrograde axonal transport to the spinal cord and brainstem, where it permanently impairs inhibitory neurotransmission by blocking gamma-aminobutyric acid and glycine release This unchecked motor stimulation clinically manifests as severe muscle rigidity, painful reflex sp...

The toxin enters peripheral motor nerves and undergoes retrograde axonal transport to the spinal cord and brainstem, where it permanently impairs inhibitory neurotransmission by blocking gamma-aminobutyric acid and glycine release

This unchecked motor stimulation clinically manifests as severe muscle rigidity, painful reflex spasms, trismus, and profound autonomic nervous system instability, creating a critical state that often requires intensive care, mechanical ventilation, and targeted adjunctive spasmolytic or sedating interventions